These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities. Zarrilli R; Giannouli M; Tomasone F; Triassi M; Tsakris A J Infect Dev Ctries; 2009 Jun; 3(5):335-41. PubMed ID: 19759502 [TBL] [Abstract][Full Text] [Related]
5. Acinetobacter in veterinary medicine, with an emphasis on Acinetobacter baumannii. van der Kolk JH; Endimiani A; Graubner C; Gerber V; Perreten V J Glob Antimicrob Resist; 2019 Mar; 16():59-71. PubMed ID: 30144636 [TBL] [Abstract][Full Text] [Related]
6. [Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates]. Eraç B; Yılmaz FF; Hoşgör Limoncu M; Oztürk I; Aydemir S Mikrobiyol Bul; 2014 Jan; 48(1):70-81. PubMed ID: 24506717 [TBL] [Abstract][Full Text] [Related]
10. Biofilm Formation and Detection of Fluoroquinolone- and Carbapenem-Resistant Genes in Multidrug-Resistant Avila-Novoa MG; Solís-Velázquez OA; Rangel-López DE; González-Gómez JP; Guerrero-Medina PJ; Gutiérrez-Lomelí M Can J Infect Dis Med Microbiol; 2019; 2019():3454907. PubMed ID: 31929848 [No Abstract] [Full Text] [Related]
11. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232 [TBL] [Abstract][Full Text] [Related]
12. Copper Resistance of the Emerging Pathogen Acinetobacter baumannii. Williams CL; Neu HM; Gilbreath JJ; Michel SL; Zurawski DV; Merrell DS Appl Environ Microbiol; 2016 Oct; 82(20):6174-6188. PubMed ID: 27520808 [TBL] [Abstract][Full Text] [Related]
13. Dahdouh E; Hajjar M; Suarez M; Daoud Z Front Cell Infect Microbiol; 2016; 6():163. PubMed ID: 27933276 [No Abstract] [Full Text] [Related]
14. Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital. Elabd FM; Al-Ayed MS; Asaad AM; Alsareii SA; Qureshi MA; Musa HA J Infect Public Health; 2015; 8(3):242-7. PubMed ID: 25466594 [TBL] [Abstract][Full Text] [Related]
15. 5-Episinuleptolide Decreases the Expression of the Extracellular Matrix in Early Biofilm Formation of Multi-Drug Resistant Acinetobacter baumannii. Tseng SP; Hung WC; Huang CY; Lin YS; Chan MY; Lu PL; Lin L; Sheu JH Mar Drugs; 2016 Jul; 14(8):. PubMed ID: 27483290 [TBL] [Abstract][Full Text] [Related]
16. Distribution of virulence genes involved in biofilm formation in multi-drug resistant Acinetobacter baumannii clinical isolates. Thummeepak R; Kongthai P; Leungtongkam U; Sitthisak S Int Microbiol; 2016 Jun; 19(2):121-129. PubMed ID: 27845499 [TBL] [Abstract][Full Text] [Related]
17. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii. Thomas VM; Brown RM; Ashcraft DS; Pankey GA Int J Antimicrob Agents; 2019 May; 53(5):663-668. PubMed ID: 30880230 [TBL] [Abstract][Full Text] [Related]
18. Clinical isolates of Acinetobacter baumannii from a Portuguese hospital: PFGE characterization, antibiotic susceptibility and biofilm-forming ability. Duarte A; Ferreira S; Almeida S; Domingues FC Comp Immunol Microbiol Infect Dis; 2016 Apr; 45():29-33. PubMed ID: 27012918 [TBL] [Abstract][Full Text] [Related]
19. Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran. Salehi B; Goudarzi H; Nikmanesh B; Houri H; Alavi-Moghaddam M; Ghalavand Z J Infect Chemother; 2018 Jul; 24(7):515-523. PubMed ID: 29555392 [TBL] [Abstract][Full Text] [Related]